Kinase Inhibitors : Methods and Protocols /
| Autor Corporativo: | |
|---|---|
| Otros Autores: | |
| Formato: | eBook |
| Lenguaje: | English |
| Publicado: |
Totowa, NJ :
Humana Press : Imprint: Humana,
2012.
|
| Edición: | 1st ed. 2012. |
| Colección: | Methods in Molecular Biology,
795 |
| Materias: |
Tabla de Contenidos:
- Targeting Cancer with Small Molecular Weight Kinase Inhibitors
- Small Molecule Protein and Lipid Kinase Inhibitors in Inflammation and Specific Models for their Evaluation
- Measuring the Activity of Leucine Rich Repeat Kinase 2 (LRRK2) – A Kinase Involved in Parkinson’s Disease
- Measuring PI3K Lipid Kinase Activity
- A Fluorescence Polarization Assay for the Discovery of Inhibitors of the Polo-box Domain of Polo-like Kinase 1
- Assessment of Hepatotoxicity Potential of Drug Candidate Molecules Including Kinase Inhibitors by Hepatocyte Imaging Assay Technology and Bile Flux Imaging Assay Technology
- Kinase Inhibitor Selectivity Profiling using Differential Scanning Fluorimetry
- Chemoproteomic Characterization of Protein Kinase Inhibitors using Immobilized ATP
- Proteome-wide identification of staurosporine-binding kinases using Capture Compound Mass Spectrometry
- Affinity Purification of Proteins Binding to Kinase Inhibitors Immobilised on Self Assembling Monolayers
- Kinase Inhibitor Profiling using Chemoproteomics
- Covalent Crosslinking of Kinases with Their Corresponding Peptide Substrates
- Receptor Tyrosine Kinase Inhibitor Profiling using Bead-based Multiplex Sandwich Immunoassays
- Monitoring Phosphoproteomic Response To Targeted Kinase Inhibitors Using Reverse-Phase Protein Microarrays
- Measuring Phosphorylation Specific Changes in Response to Kinase Inhibitors in Mammalian Cells Using Quantitative Proteomics
- Investigation of Acquired Resistance to EGFR-Targeted Therapies in Lung Cancer Using cDNA Microarrays.